Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has issued an update.
China NT Pharma Group Co., Ltd. has announced significant changes in its corporate governance structure with the appointment of Ms. Li Yifang as the company secretary, authorized representative, and agent for the acceptance of service of process and notices in Hong Kong, effective from November 25, 2025. This strategic appointment of Ms. Li, who brings extensive experience in regulatory compliance and corporate governance, is expected to enhance the company’s operational efficiency and strengthen its compliance framework, potentially impacting its positioning in the industry.
The most recent analyst rating on (HK:1011) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China NT Pharma Group Co., Ltd. stock, see the HK:1011 Stock Forecast page.
More about China NT Pharma Group Co., Ltd.
Average Trading Volume: 1,408,699
Technical Sentiment Signal: Buy
Current Market Cap: HK$546.1M
For an in-depth examination of 1011 stock, go to TipRanks’ Overview page.